"53873-024-00" National Drug Code (NDC)

Tafinlar 120 CAPSULE in 1 BOTTLE (53873-024-00)
(GlaxoSmithKline Inc)

NDC Code53873-024-00
Package Description120 CAPSULE in 1 BOTTLE (53873-024-00)
Product NDC53873-024
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameTafinlar
Non-Proprietary NameDabrafenib
Dosage FormCAPSULE
UsageORAL
Start Marketing Date20130610
Marketing Category NameAPPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT
Application NumberNDA202806
ManufacturerGlaxoSmithKline Inc
Substance NameDABRAFENIB MESYLATE
Strength75
Strength Unitmg/1
Pharmacy ClassesKinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Organic Anion Transporter 1 Inhibitors [MoA],Organic Anion Transporter 3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/53873-024-00